跳至主要内容
临床试验/NCT03461107
NCT03461107Unknown不适用

Evaluation of Beta-adrenergic Receptor Gene Polymorphisms in the Long-term Effects of Beta-blockade in Patients With Chronic Heart Failure

Tongji Hospital1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2016年4月18日最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,500
试验地点
1
主要终点
Cardiovascular death

研究概览

简要总结

The purpose of this study is to evaluate the beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade in patients with chronic heart failure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older;
  • Patients are required to have chronic heart failure (NYHA II-IV) with a left ventricular ejection fraction lower than 40%;
  • Patients are voluntary and signed informed consent.

排除标准

  • Pregnant women or plan to;
  • Participate in any drug clinical trials within 3 months;
  • Serious neurological disease (Alzheimer's disease, Parkinson syndrome, progressive lower limbs or deaf patients);
  • Previous history of cancer or tumor, or pathological examination confirmed precancerous lesions;
  • Patients refused to comply with the requirements of this study to complete the research work;
  • According to the researchers, patients can not complete the study or not to comply with the requirements of this study (because of the reasons for the management or other reasons).

结局指标

主要结局

Cardiovascular death

时间窗: up to 24 months

Heart transplantation

时间窗: up to 24 months

次要结局

  • Readmission because of cardiovascular diseases(up to 24 months)
  • All cause death(up to 24 months)
  • Heart failure recuring(up to 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dao Wen Wang

Prof

Tongji Hospital

研究点 (1)

Loading locations...

相似试验